Douglas R. Nemec concentrates on intellectual property litigation and related counseling, including providing intellectual property advice in connection with corporate transactions.
Mr. Nemec has litigated numerous cases in a wide range of technologies, from pharmaceuticals and other chemicals to IT and electronics. He has particular experience in life sciences matters, including patent litigation under the Hatch-Waxman Act. Mr. Nemec also is registered to practice before the U.S. Patent and Trademark Office, where he represents clients in proceedings before the Patent Trial and Appeal Board and other matters.
He is a member of the Skadden group recognized by BTI Consulting Group as one of the top legal advisers general counsel turn to for pharmaceutical work; by Law360 among its 2015 Technology Practice Groups of the Year for courtroom victories in the technology sector; and by The National Law Journal as one of the country’s leading IP practices in its IP Hot List for multiple years. Mr. Nemec also was named as a 2017 BTI Client Service All-Star by BTI Consulting Group. He also has been recognized as a leader in IP by Managing IP, LMG Life Sciences andIntellectual Asset Management. He is frequently involved with life sciences matters that the group handles, including defense of patent infringement claims, enforcement of patent and other IP rights and inter partes reviews related to the treatment of a variety of ailments and diseases.